Navigation
Trademark Information
Application ID
Status
Date of Application
23 March 2022
Classes
5
Attorney
Innovative Consultants[21461]
Office No.1, Ground Floor, 'B' Wing,
Aakardeep Co Op Hsg Soc, Agarkar Road,
Near Aditya Hall, Dombivali (E), Thane 421 201
Type
Device
State
Maharashtra
Country
Filing Mode
e-Filing
IP Office
MUMBAI
Used Since
04 April 2013
Valid / Upto
Description
[Class : 5] Sinuses, Respiratory Tract, Urinary Tract, Skin And Soft Tissue Pharmaceuticals And Medical Preparations For Human Beings; Pharmaceutical Preparation Used To Treat A Variety Of Bacterial Infections Including Infections Of The Throat, Ear, Nasal, And Typhoid Fever, Antibiotic That Fights And Stops The Growth Of Bacteria, Antibiotic Medicine, Amoxycillin 500 Mg Capsule..
Image (DEVICE)
Documents
| Examination Report |
Uploaded Documents
| 1 | TM-A(TRADE MARKS APPLICATION) | 23 Mar 2022 |
| 2 | Reply to Exam Report (MIS-R) | 06 Jul 2022 |
| 3 | Documents in support of Show cause Hearing (SCH) | 25 Nov 2024 |
Correspondence and Notices
| 1 | EXAMINATION REPORT | 13577761 | 01 Jun 2022 | |
| 2 | Hearing Notice (Show Cause) | 17465366 | 20 Feb 2024 | |
| 3 | Hearing Notice (Show Cause) | 18492917 | 12 Jul 2024 | |
| 4 | Adjourned Notice | 18758192 | 27 Aug 2024 | |
| 5 | Hearing Notice (Show Cause) | 19109176 | 07 Nov 2024 | |
| 6 | Adjourned Notice | 19300153 | 12 Dec 2024 |
Frequently Asked Questions
When was the trademark applied?
The application for Mioxin-500 was made on 23 March 2022.
Who is the applicant for Mioxin-500?
The trademark applicant for Mioxin-500 is BLISS GVS PHARMA.
In what class is the trademark applied to?
Mioxin-500 is applied in class(es) 5.
What is the status of the trademark application?
Application for Mioxin-500 is on Objected stage.
What is the application ID of the trademark?
Application Id allotted to Mioxin-500 is 5381153.
Who is the trademark agent or attorney?
Trademark agent or attorney for the application is Innovative Consultants.
What is the type of trademark application?
Mioxin-500 filed with the Intellectual property office as a DEVICE.